EMA’s human medicines committee (CHMP) on Friday (23 July) has recommended granting an extension of indication for the COVID-19 vaccine Spikevax, previously COVID-19 Vaccine Moderna, to include use in children aged 12 to 17 years.
EU policymakers are being urged to consider the full range of new incentive systems and pilot innovative approaches to tackle antimicrobial resistance (AMR), including Netflix-style subscription services and pull incentives.
Lyme disease cases are growing in the EU. So far the only prevention measures are clothing and fast removal of the tick, but a new vaccine underway could change this.
A study published in the Lancet has found that out of more than 70,000 adults in the UK hospitalised with severe COVID-19 disease, half developed at least one health complication during their hospitalisation, while almost one in three participants died....
As many as 1.5 million children worldwide have lost a parent, grandparent, or primary caregiver from COVID-19 during the first 14 months of the pandemic, a Lancet global study has estimated. Researchers have called for urgent investments in services to support children who lost their caregivers as the number is likely to grow.
The EU seems to be comfortable with betting on mRNA COVID vaccines for now. But just around the corner, vaccines developed under other platforms are lining up, with recombinant proteins and the whole virion-inactivated vaccines leading the way.
A Spanish company active in animal health stands ready to start clinical trials and get the EU's regulatory go-ahead for a 'deadline-proof' recombinant protein vaccine. EURACTIV spoke with the company's chief of the vaccine programme.
The European Parliament has called for the creation of a strategy to completely eliminate cancer-causing asbestos in a bid to strengthen workers' protection and reduce exposure to this common chemical.
A study by Lancet Oncology has found that 4% of all newly diagnosed cancers in 2020 may be associated with drinking alcohol, with the highest proportion, or some 6%, in Central and Eastern Europe.
The European Parliament adopted a proposal last week to broaden the mandate of the European Medicines Agency ahead of upcoming talks with member states on EMA's future role. EURACTIV takes a look at where the Parliament and the Council stand ahead of the negotiations.
Today and tomorrow (12-13 July) the Commission is hosting a matchmaking event to mobilise the development and production of COVID-19 therapeutics, another tool in the fight against COVID-19.
The EU is facing a patchwork across the bloc when it comes to travelling, despite having a fully running EU digital covid certificate. As the delta variant surges across the bloc, MEPs call for implementing harmonised measures instead of national restrictions.
COVID-19 pandemic has helped raise political awareness of health issues but the widespread misuse of antibiotics in COVID patient treatment is likely to result in increased antimicrobial resistance, health experts have warned.
Investment in research and development, together with encouraging the innovative economic models is a way to fight this silent threat, Swedish centre-right MEP Jessica Polfjärd told EURACTIV in an interview.
A new report by a multidisciplinary group of experts bringing together researchers, academia and the pharma industry, has urged policymakers to look beyond the EU's Orphan Medicinal Products (OMP) regulation to better address the unmet needs of patients with rare diseases.
Digital EU COVID certificate is a free tool that opens the EU borders for its citizens that have been vaccinated against COVID-19, have recovered from it or have had a recent negative test result.
The European Parliament voted in favour of a resolution on sexual reproductive health and rights of women on Thursday (24 June), calling on member states to ensure access to abortion, contraception and sexuality education.
While inequalities across the EU when it comes to kidney disease treatments are well-known by the European Commission, the ball is ultimately in member states' courts when it comes to expanding access, according to health stakeholders.
The European Parliament and Council reached on Tuesday (22 June) a provisional agreement on the health technology assessment (HTA), in a move to help member states take more "timely and evidence-based decisions on patient access" to their healthcare systems.
With incidences of kidney disease predicted to soar in the next decade, health stakeholders are calling for more efforts to ensure patient autonomy and invest in training for both practitioners and patients.
Research on cannabis-based medicine is still lagging behind in Germany, despite the country has one of the most developed regulatory frameworks for medical marijuana in the European Union.
The world needs to rethink intellectual property rights to get ready for the next pandemic and Europe has to do its part as a constructive partner at the negotiating table, Belgian socialist MEP Kathleen Van Brempt told EURACTIV in an interview.
The European Parliament endorsed a resolution on Wednesday (9 June) calling for a temporary waiver of COVID-19 vaccine patents, while the Commission remained firm in its opposition to such measures and said it has different plans to speed up the global vaccine rollout.
On Tuesday (8 June) the EU Parliament voted in favour of the EU digital COVID certificate initiative, bringing the EU one step closer to finalising the initiative due to come into force on 1 July.
